Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Report Format: PDF+Excel | Report ID: SR112024A8697
Buy Now

Market Overview: 

The 7 major anorexia markets reached a value of US$ 88.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 556.6 Million by 2034, exhibiting a growth rate (CAGR) of 18.14% during 2024-2034.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years 2024-2034
Historical Years
2018-2023
Market Size in 2023
US$ 88.9 Million
Market Forecast in 2034
US$ 556.6 Million
Market Growth Rate (2024-2034)
18.14%


The anorexia market has been comprehensively analyzed in IMARC's new report titled "Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Anorexia, also referred to as anorexia nervosa, is a complex and potentially life-threatening eating disorder characterized by an intense dread of gaining weight, a distorted perception of one's body, and a refusal to maintain a healthy body weight. Individuals with anorexia often have a low body weight, which they manage through self-imposed starvation, excessive exercise, and other weight control behaviors. Some of the common physical symptoms are fatigue, dizziness, hair loss, dry skin, irregular menstrual cycles in women, etc. Various psychological indications include anxiety, depression, obsessive thoughts about food and weight, etc. Many individuals may also engage in purging behaviors, such as self-induced vomiting and the misuse of laxatives or diuretics. Anorexia nervosa is diagnosed based on a combination of physical and psychological symptoms. Medical professionals will typically conduct a thorough physical examination to assess the patient's weight, body mass index, and other physical indications associated with the ailment. They may also suggest blood tests to rule out further possible causes of the symptoms. Additionally, medical professionals will evaluate an individual's psychological indications through clinical interviews, psychological evaluations, questionnaires, etc.

Anorexia Market

The rising cases of imbalance in certain neurotransmitters, particularly serotonin and dopamine, which contribute to the complex interplay of biological, psychological, and environmental factors that underlie the disorder, are primarily driving the anorexia market. Besides this, the widespread adoption of various antidepressants like fluoxetine to manage comorbid conditions, such as depression and anxiety, in patients is acting as another significant growth-inducing factor. Additionally, the inflating usage of dialectical behavior therapy (DBT) for treating individuals with anorexia who also have borderline personality disorder is further bolstering the market growth. The therapy focuses on mindfulness, distress tolerance, emotional regulation, and interpersonal effectiveness. Apart from this, the introduction of numerous awareness programs that aim to educate individuals about healthy eating habits and body image, as well as identify and address risk factors for eating disorders, is also creating a positive outlook for the market. Moreover, the increasing utilization of virtual reality therapy, which allows patients to confront their fears in a controlled environment to help them develop more positive attitudes toward food and their bodies, is expected to drive the anorexia market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the anorexia market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for anorexia and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the anorexia market in any manner.

Time Period of the Study

  • Base Year: 2023
  • Historical Period: 2018-2023
  • Market Forecast: 2024-2034


Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the anorexia market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the anorexia market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current anorexia marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug overview
  • Mechanism of action
  • Regulatory status
  • Clinical trial results
  • Drug uptake and market performance    
     

Late-Stage Pipeline Drugs

  • Drug overview
  • Mechanism of action
  • Regulatory status
  • Clinical trial results
  • Drug uptake and market performance
     
Drugs Company Name
Psilocybin COMPASS Pathways


*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

  • How has the anorexia market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
  • What was the country-wise size of the anorexia market across the seven major markets in 2023 and what will it look like in 2034?
  • What is the growth rate of the anorexia market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the number of prevalent cases (2018-2034) of anorexia across the seven major markets?
  • What is the number of prevalent cases (2018-2034) of anorexia by age across the seven major markets?
  • What is the number of prevalent cases (2018-2034) of anorexia by gender across the seven major markets?
  • How many patients are diagnosed (2018-2034) with anorexia across the seven major markets?
  • What is the size of the anorexia patient pool (2018-2023) across the seven major markets?
  • What would be the forecasted patient pool (2024-2034) across the seven major markets?
  • What are the key factors driving the epidemiological trend of anorexia?
  • What will be the growth rate of patients across the seven major markets?
     

Anorexia: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for anorexia drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the anorexia market?
  • What are the key regulatory events related to the anorexia market?
  • What is the structure of clinical trial landscape by status related to the anorexia market?
  • What is the structure of clinical trial landscape by phase related to the anorexia market?
  • What is the structure of clinical trial landscape by route of administration related to the anorexia market? 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More